US Congress House Bill 1925 (Prior Session Legislation)

---

Spectrum: Partisan Bill (Democrat 7-0)
Status: Introduced on May 13 2011 - 25% progression, died in committee
Action: 2011-07-11 - Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
Pending: House Subcommittee on Crime, Terrorism, and Homeland Security Committee
Text: Latest bill text (Introduced) [PDF]

Prescription Drug Abuse Prevention and Treatment Act of 2011 - Amends the Public Health Service Act to direct the Administrator of the Substance Abuse and Mental Health Services Administration to award grants to states and nonprofit entities for consumer education about opioid abuse, including methadone abuse. Amends the Controlled Substances Act to: (1) set forth training requirements for practitioners registered to prescribe or dispense methadone or other opioids; and (2) require each registered opioid treatment clinic to make acceptable arrangements for each patient who is restricted from having a take-home dose of a controlled substance related to treatment to receive a dose of that substance under appropriate supervision when the clinic is closed. Prohibits any individual or entity (except hospitals that provide direct patient supervision) from prescribing or dispensing a 40-mg diskette of methadone unless such prescription or dispensation is consistent with the current Drug Enforcement Administration (DEA) methadone policy, until the date the Controlled Substances Clinical Standards Commission: (1) publishes dosing guidelines for methadone, and (2) finds that such 40-mg diskettes are safe and clinically appropriate. Requires the Secretary of Health and Human Services (HHS) to establish such Commission to develop and publish guidelines related to methadone use, including safe dosing guidelines for all forms of methadone and benchmark guidelines for the reduction of methadone abuse. Requires states receiving controlled substances monitoring program grants to: (1) provide information, upon request, to drug enforcement officials relating to an individual who is the subject of an active drug-related investigation; and (2) require opioid-related deaths to be reported to the Administrator. Directs the Administrator to develop a Model Opioid Treatment Program Mortality Report. Requires the Administrator to establish and implement, through the National Center for Health Statistics, a National Opioid Death Registry to track opioid-related deaths.

Prescription Drug Abuse Prevention and Treatment Act of 2011

Rep. Nick Rahall [D-WV]	Rep. Brian Higgins [D-NY]	Rep. William Keating [D-MA]	Rep. Stephen Lynch [D-MA]
Rep. James McGovern [D-MA]	Rep. Michael Michaud [D-ME]	Rep. Paul Tonko [D-NY]

Date	Chamber	Action
2011-07-11	House	Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.
2011-05-23	House	Referred to the Subcommittee on Health.
2011-05-13	House	Referred to House Judiciary
2011-05-13	House	Referred to House Energy and Commerce
2011-05-13	House	Referred to the Committee on Energy and Commerce, and in addition to the Committee on the Judiciary, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

SB507 (Same As) 2011-03-08 - Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Type	Source
Summary	https://www.congress.gov/bill/112th-congress/house-bill/1925/all-info
Text	https://www.congress.gov/112/bills/hr1925/BILLS-112hr1925ih.pdf